10 Best Stocks That Will Always Grow

6. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 88

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced medicines for serious diseases. Its medicines fall into various therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.

Leerink Partners analyst David Risinger maintained a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) on April 14. Bristol-Myers Squibb Company (NYSE:BMY) surpassed analyst estimates with its fiscal Q4 2024 and full year 2024 earnings, reporting an EPS of $1.67 that outperformed the expected $1.46. Revenue for fiscal Q4 2024 rose to $12.3 billion, exceeding the expected $11.57 billion and reflecting its strong operations.

The company has also exhibited strong dividend growth performance, maintaining dividend payments for 35 consecutive years with eighth consecutive years of increases. Its free cash flow is a significant metric for investors, as it totaled $13.9 billion last year, considerably more than the $4.9 billion it paid out in dividends. Bristol-Myers Squibb Company (NYSE:BMY) is thus in a position to weather a potential slowdown in its operations without affecting its dividend, even repaying its debt in the long term through this buffer.

The company also has a strong drug portfolio and robust pipeline due to acquisitions and partnerships, forming the base of a wide economic moat and ranking sixth on our list of the top stocks to buy that will always grow.